Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.16.3.1 (
ceruloplasmin
)
5,074
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The blue copper protein
caeruloplasmin
is synthesized mainly by hepatocytes. An alternative transcript for
caeruloplasmin
produced in certain extrahepatic tissues, CP-1, contains an additional 12 nucleotides encoding 4 amino acids not present in the hepatic transcript,
CP-2
[Yang, Friedrichs, Cupples, Bonifacio, S Sanford, Horton & Bowman (1990) J. Biol. Chem. 265, 10780-10785]. We have demonstrated transcription of
caeruloplasmin
mRNA by a well-differentiated human uterine epithelial adenocarcinoma cell line, Ishikawa, and by human uterine endometrium and purified endometrial glands. Identical
CP-2
nucleotide sequences were obtained for partial
caeruloplasmin
transcripts from human liver and Ishikawa cells, indicating that
CP-2
transcripts are produced by uterine epithelial lining cells. The synthesis of
caeruloplasmin
protein was demonstrated for Ishikawa cells and another uterine adenocarcinoma cell line, ECC1. Peptide-mapping analysis indicated that
caeruloplasmin
secreted by Ishikawa cells was structurally identical with the protein synthesized by the human hepatoblastoma cell line HepG2. The secretion of a 135,000-M(r)
caeruloplasmin
by Ishikawa and ECC1 cells, comparable with that of the human hepatoblastoma cell line, HepG2, indicated similar processing of uterine and hepatic
caeruloplasmin
. Incorporation of 67Cu into
caeruloplasmin
was demonstrated for Ishikawa and ECC1 cells, suggesting that the human uterus produces a bioactive form of
caeruloplasmin
and possesses the necessary metal transporters and intracellular machinery for copper incorporation into this protein.
...
PMID:Caeruloplasmin biosynthesis by the human uterus. 146 66
Ceruloplasmin (CP) is a plasma glycoprotein that transports copper throughout the body. In previous studies (Yang, F., Naylor, S., Lum, J., Cutshaw, S., McCombs, J., Naberhaus, K., McGill, J., Adrian, G., Moore, C., Barnett, D., and Bowman, B. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 3277-3261), two CP cDNA clones, CP-1 and
CP-2
, from a human cDNA library, differed from each other by the presence or absence, respectively, of 12 nucleotide bases encoding a deduced sequence of Gly-Glu-Tyr-Pro near the carboxyl-terminal region of the
ceruloplasmin
molecule. Examination of genomic DNA demonstrates that the two CP mRNAs are produced from a single gene by alternative spliced patterns. The additional amino acids deduced in CP-1 are products of alternative splicing within an intron of the CP gene at a site 12 nucleotide bases 3' to the commonly used site of
CP-2
. The CP-1 mRNA transcript encoding four extra amino acids appeared as a minor species accompanying
CP-2
mRNA in placenta and chondrocytes. CP-1 mRNA was the predominant CP transcript in a lymphoblastic leukemia cell line, CEM. The mRNA examined from other tissues contained only
CP-2
mRNA transcripts. These findings predict that alternative RNA splicing may lead to the differential expression of CP genomic sequences and produce alternate isoforms from a single CP gene in specific tissues.
...
PMID:Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing. 235 23
We showed previously that
ceruloplasmin
associates with the H chain of rat liver ferritin during iron loading into ferritin such that the iron oxidized by
ceruloplasmin
was deposited into ferritin [S.-H. Juan et al. (1997) Arch. Biochem. Biophys. 341, 280-286]. Three synthetic decapeptides derived from domains 2, 4, and 6 of
ceruloplasmin
, referred to
CP-2
, CP-4, and CP-6, were utilized to identify a possible binding site on
ceruloplasmin
for ferritin. Two of the peptides, CP-4 and CP-6, were found to inhibit iron loading into the recombinant ferritin H chain homopolymer (rH-Ft) by
ceruloplasmin
. The extent of inhibition of iron loading into ferritin by
ceruloplasmin
by CP-6, but not CP-4, varied with pH, whereas the inhibitory effect remained constant in increasing concentrations of NaCl. The addition of rH-Ft quenched the fluorescence emission of CP-4 and CP-6, but not
CP-2
. The quenching of fluorescence was used to estimate dissociation constants for the peptides. Iron loading into ferritin in Hepes buffer was not affected in the presence of these peptides. In addition, synthetic peptides corresponding to the BC loop of ferritin H and L chains were utilized to localize an interaction site on ferritin for
ceruloplasmin
. The BC loop of H chain but not L chain of ferritin stimulated the
ferroxidase
activity of
ceruloplasmin
. Only the BC loop of ferritin H chain decreased the amount of iron loading into ferritin by
ceruloplasmin
.
...
PMID:Studies on the interaction between ferritin and ceruloplasmin. 964 67